세계의 마이크로바이옴 검사 키트 시장 보고서(2025년)
Microbiome Testing Kit Global Market Report 2025
상품코드 : 1855925
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,650,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,612,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,575,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 마이크로바이옴 검사 키트 시장 규모는 최근 급격히 확대되고 있습니다. 2024년 13억 1,000만 달러에서 2025년에는 16억 3,000만 달러에 달하고, CAGR 24.5%로 확대될 것으로 보입니다. 이 실적기간의 성장은 소화기의 건강에 대한 사회적 관심 증가, 중성 유전체 검사의 채용 증가, 마이크로바이옴 기능에 대한 소비자의 의식 증가, 예방 헬스케어 캠페인의 확대, 생활습관병의 유병률 상승에 기인하고 있습니다.

마이크로바이옴 검사 키트 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년까지 CAGR 24.1%로 38억 8,000만 달러로 성장할 것으로 보입니다. 예측 기간의 성장 원동력은 맞춤형 의료에 대한 수요 증가, 재택에서의 자기 검사 보급 확대, 장뇌 관련 질환의 유병률 증가, 마이크로바이옴 치료제 투자 증가, 증거 기반 의료 및 정밀 치료에 대한 수요 증가입니다. 예측기간의 주요 동향으로는 차세대 시퀀싱 기술의 발전, 모바일 헬스 용도과의 통합, AI를 활용한 마이크로바이옴 해석의 혁신, 신속한 재택 검사 키트의 개발, 표준화된 임상 보고 툴의 진전 등을 들 수 있습니다.

개인화된 의료에 대한 수요 증가는 앞으로 수년간 마이크로바이옴 검사 키트 시장의 성장을 가속할 것으로 예측됩니다. 개인화된 의료는 개인별 유전자 프로파일, 라이프스타일, 환경에 따라 치료 및 예방 전략을 맞춤화하는 것입니다. 이 접근법은 유전적 차이를 정확하게 파악하고 개인화된 치료를 가능하게 하는 유전체학의 진보로 큰 지지를 얻고 있습니다. 마이크로바이옴 검사 키트는 개인의 미생물 구성에 대한 자세한 통찰력을 제공하여 맞춤형 의료를 지원하고 맞춤형 건강 관리에 도움이 됩니다. 이 키트는 전반적인 건강을 증진시키고 질병을 예방하는 데 도움이 되는 정확하고 데이터 중심의 조언을 제공하여 식사 및 라이프 스타일 조정의 불확실성을 줄입니다. 예를 들어, 2024년 2월 미국 비영리 단체인 맞춤형 의료연합(PMC)은 미국 식품의약국(FDA)이 2023년 26개 개별화 신약을 승인했다고 보고했습니다(2022년은 12개). 이러한 맞춤형 의료에 대한 수요 증가는 마이크로바이옴 검사 키트 시장의 확대에 기여하고 있습니다.

마이크로바이옴 검사 키트 업계의 주요 기업은 차세대 시퀀서를 이용한 장내 마이크로바이옴 분석 등 개인화된 장 건강에 대한 지식과 식사 권장을 제공하는 혁신적인 제품을 개발하고 있습니다. 이 기술은 모든 장내 미생물의 DNA를 신속하게 해독하고 그 유형, 존재량, 건강에 미치는 영향의 가능성을 밝혀줍니다. 예를 들어, 2025년 1월, 한국의 생명공학 기업인 CJ Bioscience Inc.는 개인화된 장의 건강 정보를 제공하는 소비자 직접 판매 장내 세균총 검사인 SMILE GUT를 발표했습니다. 이 키트는 차세대 시퀀서와 인공지능을 결합하여 대변 샘플을 분석하고 미생물 다양성, 유익균과 유해균 균형, 건강한 장내 프로파일과의 적합성을 측정하는 장내 마이크로바이옴 지표 점수를 계산합니다. 프로바이오틱스 및 식사 권장사항과 같은 맞춤형 건강 조언을 제공하고 14영업일 이내에 결과가 나오므로 사용자는 장 건강을 더 잘 관리할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

A microbiome testing kit is a diagnostic tool designed to analyze microbial communities, including bacteria, viruses, and fungi, in a specific environment such as the human gut, skin, or oral cavity. These kits provide insights into an individual's microbiome composition, supporting assessments of health, nutrition, and potential disease risk factors.

The primary product types of microbiome testing kits are at-home testing kits and laboratory-based testing kits. At-home testing kits allow individuals to collect and analyze gut or other body microbiota samples from home, offering personalized insights into microbial composition, diversity, and overall health. They utilize various sample types, including stool, saliva, and skin, and are applied in areas such as gut health, skin health, nutrition and diet, disease risk assessment, and other applications. Distribution channels include online pharmacies, retail stores, and other outlets. Key end-users include individuals, hospitals and clinics, research and academic institutes, and related organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The microbiome testing kit market research report is one of a series of new reports from The Business Research Company that provides microbiome testing kit market statistics, including microbiome testing kit industry global market size, regional shares, competitors with a microbiome testing kit market share, detailed microbiome testing kit market segments, market trends and opportunities, and any further data you may need to thrive in the microbiome testing kit industry. This microbiome testing kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microbiome testing kit market size has grown exponentially in recent years. It will grow from $1.31 billion in 2024 to $1.63 billion in 2025 at a compound annual growth rate (CAGR) of 24.5%. The growth in the historic period is attributed to increasing public focus on digestive wellness, rising adoption of nutrigenomics testing, growing consumer awareness of microbiome functions, expansion of preventive healthcare campaigns, and higher prevalence of lifestyle-related diseases.

The microbiome testing kit market size is expected to see exponential growth in the next few years. It will grow to $3.88 billion in 2029 at a compound annual growth rate (CAGR) of 24.1%. The growth in the forecast period is driven by rising demand for personalized medicine, greater adoption of at-home self-testing, increasing prevalence of gut-brain related disorders, higher investment in microbiome therapeutics, and growing demand for evidence-based medicine and precision therapeutics. Key trends in the forecast period include advancements in next-generation sequencing technologies, integration with mobile health applications, innovation in AI-driven microbiome analytics, development of rapid home testing kits, and progress in standardized clinical reporting tools.

The rising demand for personalized medicine is anticipated to drive growth in the microbiome testing kit market in the coming years. Personalized medicine customizes treatment and prevention strategies based on an individual's unique genetic profile, lifestyle, and environment. This approach has gained traction largely due to advancements in genomics, which allow for the accurate identification of genetic differences and individualized treatments. Microbiome testing kits support personalized medicine by delivering detailed insights into a person's microbial makeup, making them valuable for tailored health management. These kits reduce uncertainty in dietary and lifestyle adjustments by offering precise, data-driven advice that enhances overall health and helps prevent diseases. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, compared to 12 in 2022. This growing demand for personalized medicine is thus contributing to the expansion of the microbiome testing kit market.

Leading companies in the microbiome testing kit industry are developing innovative products such as next-generation sequencing-based gut microbiome analysis to deliver personalized gut health insights and dietary recommendations. This technique rapidly decodes the DNA of all gut microbes to determine their types, abundance, and possible effects on health. For instance, in January 2025, CJ Bioscience Inc., a biotechnology firm from South Korea, introduced SMILE GUT, a direct-to-consumer gut microbiome test that provides personalized gut health information. The kit uses next-generation sequencing combined with artificial intelligence to analyze stool samples and produces a gut microbiome index score that measures microbial diversity, the balance between beneficial and harmful bacteria, and conformity with healthy gut profiles. It offers customized health advice, including probiotic and dietary recommendations, with results available within 14 business days, enabling users to better manage their gut health.

In January 2025, Pooch and Mutt Ltd., a pet food and treat company based in the UK, acquired Biome9 for an undisclosed sum. This acquisition allows Pooch and Mutt to enhance its science-driven pet nutrition products by delivering personalized, microbiome-based gut health solutions for dogs. Biome9 Limited, also UK-based, provides a microbiome testing kit designed specifically for dogs called the gutdiscovery test.

Major players in the microbiome testing kit market are OraSure Technologies Inc., Genova Diagnostics Inc., Ombre Health Inc., Viome Inc., Zymo Research Corporation, EasyDNA Pty Ltd., Psomagen Inc., DayTwo Ltd., Atlas Biomed Group Limited., BIOHM Health Inc., Mapmygenome India Limited, Biomes NGS GmbH, Carbiotix AB, CosmosID Inc., Juno Bio Ltd., Microba Life Sciences Limited., Sun Genomics Inc., Unseen Bio ApS, InnerBuddies, and MyMicroZoo B.V.

North America was the largest region in the personalized genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in microbiome testing kit report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the microbiome testing kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microbiome testing kit market consists of sales of respiratory microbiome kits, infant microbiome kits, environmental microbiome kits, sample preservation and transport kits, next-generation sequencing (NGS) panels, and data interpretation platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microbiome Testing Kit Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microbiome testing kit market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for microbiome testing kit ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microbiome testing kit market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Microbiome Testing Kit Market Characteristics

3. Microbiome Testing Kit Market Trends And Strategies

4. Microbiome Testing Kit Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Microbiome Testing Kit Growth Analysis And Strategic Analysis Framework

6. Microbiome Testing Kit Market Segmentation

7. Microbiome Testing Kit Market Regional And Country Analysis

8. Asia-Pacific Microbiome Testing Kit Market

9. China Microbiome Testing Kit Market

10. India Microbiome Testing Kit Market

11. Japan Microbiome Testing Kit Market

12. Australia Microbiome Testing Kit Market

13. Indonesia Microbiome Testing Kit Market

14. South Korea Microbiome Testing Kit Market

15. Western Europe Microbiome Testing Kit Market

16. UK Microbiome Testing Kit Market

17. Germany Microbiome Testing Kit Market

18. France Microbiome Testing Kit Market

19. Italy Microbiome Testing Kit Market

20. Spain Microbiome Testing Kit Market

21. Eastern Europe Microbiome Testing Kit Market

22. Russia Microbiome Testing Kit Market

23. North America Microbiome Testing Kit Market

24. USA Microbiome Testing Kit Market

25. Canada Microbiome Testing Kit Market

26. South America Microbiome Testing Kit Market

27. Brazil Microbiome Testing Kit Market

28. Middle East Microbiome Testing Kit Market

29. Africa Microbiome Testing Kit Market

30. Microbiome Testing Kit Market Competitive Landscape And Company Profiles

31. Microbiome Testing Kit Market Other Major And Innovative Companies

32. Global Microbiome Testing Kit Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microbiome Testing Kit Market

34. Recent Developments In The Microbiome Testing Kit Market

35. Microbiome Testing Kit Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기